REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Biosalud De La Costa S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Pharmacies and Drug Stores
Full name: Ips Biosalud De La Costa S.A.S Profile Updated: February 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Ips Biosalud De La Costa S.A.S is an enterprise in Colombia, with the main office in Sincelejo. The enterprise operates in the Diagnostic Imaging Centers industry. The company was established on May 14, 2012. From the latest financial highlights, Ips Biosalud De La Costa S.A.S reported a net sales revenue drop of 13.41% in 2025. Its’ total assets recorded a negative growth of 11.53%.

Headquarters
Cr 22 18 06 Br Ford
Sincelejo; Sucre;

Contact Details: Purchase the Ips Biosalud De La Costa S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Ips Biosalud De La Costa S.A.S report to view the information.
Financial Auditors:
Purchase the Ips Biosalud De La Costa S.A.S report to view the information.
Incorporation Date:
May 14, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Biosalud De La Costa S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-13.41%
Total Operating Revenue
-13.41%
Operating Profit
9.96%
EBITDA
5.03%
Net Profit/Loss for the Period
N/A
Total Assets
-11.53%
Total Equity
37.56%
Operating Profit Margin
1.21%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
2.71%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?